MedTrace Logo

Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer

NCT00156052 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1234

Last updated 2015-06-08

No results posted yet for this study

Summary

To determine if hypofractionated radiotherapy to the whole breast (4,250 cGy/16 fractions over 22 days) is equally effective to standard fractionated radiotherapy (5,000 cGy/25 fractions over 35 days) in women with node negative breast cancer who have undergone lumpectomy.

The primary outcome is local breast recurrence and secondary outcomes include morbidity and cost effectiveness.

Conditions

Interventions

RADIATION

Conventional whole breast radiation schedule

RADIATION

Hypofractionated whole breast radiation schedule

Sponsors & Collaborators

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Tim Whelan, MD · Juravinski Cancer Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156052 on ClinicalTrials.gov